Nkarta (NKTX) Depreciation & Amortization (CF) (2019 - 2026)

Nkarta's quarterly Depreciation & Amortization (CF) came in at $2.3 million in Q1 2026, up 1.78% year-on-year from $2.3 million in Q1 2025, and up 3.68% quarter-over-quarter from $2.3 million in Q4 2025.

Nkarta has reported Depreciation & Amortization (CF) for 8 years, with the latest figure at $2.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 1.78% year-over-year to $2.3 million; the trailing twelve-month figure through Mar 2026 stood at $9.2 million (changed 0.41% YoY), and the FY2025 full-year result was $9.2 million, changed 0.45% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 stood at $2.3 million, up from $2.3 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $2.3 million in Q3 2024, with the low at $610000.0 in Q1 2022.
  • Average Depreciation & Amortization (CF) over 5 years is $1.7 million, with a median of $2.3 million recorded in 2024.
  • Year-over-year, Depreciation & Amortization (CF) soared 208.78% in 2023 and slipped 1.75% in 2025.
  • Tracing NKTX's Depreciation & Amortization (CF) over 5 years: stood at $729000.0 in 2022, then soared by 208.78% to $2.3 million in 2023, then gained by 1.64% to $2.3 million in 2024, then fell by 1.35% to $2.3 million in 2025, then climbed by 3.68% to $2.3 million in 2026.
  • The last three Depreciation & Amortization (CF) figures came in at $2.3 million (Q1 2026), $2.3 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1,395.22
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 55.90 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 123.20 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 13.55 Mn
10 Nkarta 232.80 Mn 232.80 Mn - 2.34 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.34 Mn
Mar 31, 2026 2.34 Mn
Dec 31, 2025 2.26 Mn
Dec 31, 2025 2.26 Mn
Sep 30, 2025 2.31 Mn
Sep 30, 2025 2.31 Mn
Jun 30, 2025 2.33 Mn
Jun 30, 2025 2.33 Mn
Mar 31, 2025 2.30 Mn
Mar 31, 2025 2.30 Mn
Dec 31, 2024 2.29 Mn
Dec 31, 2024 2.29 Mn
Sep 30, 2024 2.35 Mn
Sep 30, 2024 2.35 Mn
Jun 30, 2024 2.26 Mn
Jun 30, 2024 2.26 Mn
Mar 31, 2024 2.26 Mn
Mar 31, 2024 2.26 Mn
Dec 31, 2023 2.25 Mn
Dec 31, 2023 2.25 Mn
Sep 30, 2023 1.98 Mn
Sep 30, 2023 1.98 Mn
Jun 30, 2023 839,000.00
Jun 30, 2023 839,000.00
Mar 31, 2023 797,000.00
Mar 31, 2023 797,000.00
Dec 31, 2022 729,000.00
Dec 31, 2022 729,000.00
Sep 30, 2022 665,000.00
Sep 30, 2022 665,000.00
Jun 30, 2022 633,000.00
Jun 30, 2022 633,000.00
Mar 31, 2022 610,000.00
Mar 31, 2022 610,000.00
Dec 31, 2021 556,000.00
Dec 31, 2021 556,000.00
Sep 30, 2021 533,000.00
Sep 30, 2021 533,000.00
Jun 30, 2021 366,000.00
Jun 30, 2021 366,000.00
Mar 31, 2021 301,000.00
Mar 31, 2021 301,000.00
Dec 31, 2020 283,000.00
Dec 31, 2020 283,000.00
Sep 30, 2020 222,000.00
Sep 30, 2020 222,000.00
Jun 30, 2020 140,000.00
Jun 30, 2020 140,000.00
Mar 31, 2020 141,000.00
Mar 31, 2020 141,000.00
Dec 31, 2019 129,000.00
Dec 31, 2019 129,000.00
Sep 30, 2019 107,104.00
Sep 30, 2019 107,104.00